Picture of CEL-SCI logo

CVM CEL-SCI Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for CEL-SCI, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K/A10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-22.1-30.3-36.4-36.7-32.2
Depreciation
Non-Cash Items9.7114.115.912.17.16
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4.53-1.27-0.5152.54-1.78
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-16.3-15.3-18.8-18.2-22.8
Capital Expenditures-0.178-2.69-9.02-0.638-0.362
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.158-6.176.13-0.01
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Cash from Investing Activities-0.336-2.69-15.25.49-0.372
Financing Cash Flow Items-0.163-0.7531.290.617-0.745
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14.82554.5-0.6384.69
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.877.0620.6-13.4-18.5